Skip to content

Escalon Medical Corp.: 10-Q filed 2014-05-14

What Escalon Medical Corp. reported in its quarterly report filed 2014-05-14 (fiscal Q3 2014): 38 published measures, 109 facts as tagged in accession 0000862668-14-000004.

This filing

Form
10-Q (quarterly report)
Filed
2014-05-14
Fiscal period
fiscal Q3 2014
Accession
0000862668-14-000004 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Escalon Medical Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-03-317,548,312USD
At 2013-06-307,272,165USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-03-313,722,137USD
At 2013-06-303,443,239USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-03-313,826,175USD
At 2013-06-303,828,926USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-03-312,409,396USD
At 2013-06-302,654,701USD
At 2013-03-313,283,494USD
At 2012-06-30890,623USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-03-3186,084USD90
2013-07-01 to 2014-03-31-9,223USD274
2013-01-01 to 2013-03-31-285,864USD90
2012-07-01 to 2013-03-313,274,082USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-07-01 to 2014-03-31-225,471USD274
2012-07-01 to 2013-03-31-1,311,031USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-07-01 to 2014-03-310USD274
2012-07-01 to 2013-03-318,618USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-07-01 to 2014-03-310USD274
2012-07-01 to 2013-03-31-2,787,480USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-07-01 to 2014-03-31-19,834USD274
2012-07-01 to 2013-03-316,491,382USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-03-31-65,733,565USD
At 2013-06-30-65,724,342USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-01-01 to 2014-03-317,526,430shares90
2013-07-01 to 2014-03-317,526,430shares274
2013-01-01 to 2013-03-317,526,430shares90
2012-07-01 to 2013-03-317,526,430shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-01-01 to 2014-03-317,526,430shares90
2013-07-01 to 2014-03-317,526,430shares274
2013-01-01 to 2013-03-317,526,430shares90
2012-07-01 to 2013-03-317,526,430shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-01-01 to 2014-03-310.01USD/shares90
2013-07-01 to 2014-03-310USD/shares274
2013-01-01 to 2013-03-31-0.04USD/shares90
2012-07-01 to 2013-03-310.44USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-01-01 to 2014-03-310.01USD/shares90
2013-07-01 to 2014-03-310USD/shares274
2013-01-01 to 2013-03-31-0.04USD/shares90
2012-07-01 to 2013-03-310.44USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-01-01 to 2014-03-310USD90
2013-07-01 to 2014-03-310USD274
2013-01-01 to 2013-03-310USD90
2012-07-01 to 2013-03-310USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-03-3126,482USD
At 2013-06-3012,594USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-03-31112,308USD90
2013-07-01 to 2014-03-3160,719USD274
2013-01-01 to 2013-03-31-294,865USD90
2012-07-01 to 2013-03-31-781,847USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-03-316,786,597USD
At 2013-06-306,522,826USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-01-01 to 2014-03-310USD90
2013-07-01 to 2014-03-310USD274
2013-01-01 to 2013-03-310USD90
2012-07-01 to 2013-03-3179,479USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-03-312,859,752USD
At 2013-06-302,519,533USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-03-311,002,368USD
At 2013-06-30672,926USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-03-31125,027USD
At 2013-06-30125,027USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-03-315,200USD
At 2013-06-306,712USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-03-311,686,857USD
At 2013-06-301,725,841USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-03-312,465,056USD
At 2013-06-301,853,686USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2014-01-01 to 2014-03-311,250,159USD90
2013-07-01 to 2014-03-313,743,548USD274
2013-01-01 to 2013-03-311,409,274USD90
2012-07-01 to 2013-03-314,303,775USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-01-01 to 2014-03-31315,850USD90
2013-07-01 to 2014-03-311,016,082USD274
2013-01-01 to 2013-03-31272,889USD90
2012-07-01 to 2013-03-31803,256USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-03-317,526,430shares
At 2013-06-307,526,430shares
At 2008-11-207,526,430shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-03-3169,552,214USD
At 2013-06-3069,413,628USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-03-311,132,111USD
At 2013-06-301,171,281USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-01-01 to 2014-03-31112,354USD90
2013-07-01 to 2014-03-3168,426USD274
2013-01-01 to 2013-03-31-283,761USD90
2012-07-01 to 2013-03-31-781,424USD274

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2014-01-01 to 2014-03-31112,354USD90
2013-07-01 to 2014-03-3168,426USD274
2013-01-01 to 2013-03-31-283,761USD90
2012-07-01 to 2013-03-31-781,424USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-01-01 to 2014-03-3186,084USD90
2013-07-01 to 2014-03-31-9,223USD274
2013-01-01 to 2013-03-31-285,864USD90
2012-07-01 to 2013-03-313,789,704USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-07-01 to 2014-03-317,458USD274
2012-07-01 to 2013-03-3116,265USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-01-01 to 2014-03-310USD90
2013-07-01 to 2014-03-317,543USD274
2013-01-01 to 2013-03-3111,033USD90
2012-07-01 to 2013-03-3179,770USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-01-01 to 2014-03-3146USD90
2013-07-01 to 2014-03-317,707USD274
2013-01-01 to 2013-03-3111,104USD90
2012-07-01 to 2013-03-31423USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-07-01 to 2014-03-31-38,984USD274
2012-07-01 to 2013-03-3136,230USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-07-01 to 2014-03-31611,370USD274
2012-07-01 to 2013-03-31577,400USD274

Inspect the source

Entity
Escalon Medical Corp. / CIK 0000862668
Captured
2026-09-20T04:59:43.148Z
SEC response SHA-256
1553c3790334a15d4c4528d0e1ce16eac37d12130ed9cd66f6b338c07ce2533d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000862668.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))